News
The breast cancer risk assessment test that detected Olivia Munn's aggressive Luminal B cancer has now identified breast ...
AbbVie has placed a high price on that potential, coughing up $700 million for a phase 1 candidate and offering up to $1.225 ...
After Olivia Munn was diagnosed with breast cancer in 2023, she urged her mom and sister to take a risk assessment test.
Princess Kate's charm and presence have become a cornerstone of the Royal Family’s popularity. From recent dazzling ...
In discussions with multiple potential animal health company partners to collaborate to bring Canalevia®, conditionally ...
While sites have not been finalized, the clinical trial will likely take place in Houston, the company's chief science ...
Explore more
Some results have been hidden because they may be inaccessible to you
Show inaccessible results